SignalFDA/Bio

MERCK (MRK) SURGES ON A MELANOMA WIN. CAN INTISMERAN EXTEND KEYTRUDA’S GROWTH RUNWAY? - YAHOO

Merck surges on melanoma win; intismeran could extend Keytruda’s growth runway.

What changed

Merck surges on melanoma win; intismeran could extend Keytruda’s growth runway.

Why it matters

Merck surges on melanoma win; intismeran could extend Keytruda’s growth runway. — impact context not separately stored; see What changed.

Sources